Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-07-10

EMA Authorised: Vaxchora (vibrio cholerae, strain cvd 103-hgr, live) — Bavarian Nordic A/S

View source ↗

Summary

Vaxchora (live Vibrio cholerae, strain CVD 103-HgR) has been authorised by the EMA for use in cholera.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaxchora (Vibrio cholerae live attenuated vaccine (strain CV103-HGR))

Snippet

Status: Authorised. Therapeutic area: Cholera. MAH: Bavarian Nordic A/S. Decision date: 09/07/2026